Biosimilars are large, complex molecules with high similarity to an existing and licensed biotherapeutic product, developed for use when the current patent comes to an end. In recent years, biosimilars have led to more accessible treatment for a large variety of diseases due to more competitive pricing and greater accessibility for a large variety of diseases.
Expert Insight: Don t miss out on these 10 expert webinars
Explore topics from micro- and nanoscale LC-MS analysis to NGS sample quality control, EEM and A-TEEM spectroscopy, and oligonucleotide analysis
24 May 2021
SelectScience
® hosts dozens of informative and insightful free webinars for scientists every month, featuring world-class speakers at the very forefront of their respective fields. In this regular feature, we highlight the events you won t want to miss over the next week or so, as well as some of our top on-demand webinars. Register now to save your spot and hear from experts as they discuss the latest research and technologies in their fields, from micro- and nanoscale LC-MS analysis and NGS sample quality control to EEM and A-TEEM spectroscopy and oligonucleotide analysis.